Dulac Edward J III 4
4 · FATE THERAPEUTICS INC · Filed Jan 10, 2024
Insider Transaction Report
Form 4
Dulac Edward J III
Chief Financial Officer
Transactions
- Sale
Common Stock
2024-01-09$4.37/sh−7,028$30,712→ 105,775 total
Footnotes (2)
- [F1]Required number of shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of 4,503 shares of Common Stock underlying RSUs granted to the Reporting Person on January 20, 2021 and 8,326 shares of Common Stock underlying RSUs granted to the Reporting Person on January 25, 2022. This sale was made pursuant to an irrevocable election by the Reporting Person to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.
- [F2]Represents the weighted average sale price of the shares sold ranging from $4.02 to $4.51 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each price within the ranges set forth in this footnote.